
Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Study finds mutation of TP53 gene impacts effect of chemotherapy in colon cancer patients.

Ineffective antiretroviral regimens, improper dosing, and drug interactions are the most common medication errors in HIV patients.

Sharing genetic and clinical information from cancer patients could allow researchers to better personalize cancer treatments.

Compound in horseradish called glucosinolates found to eliminate cancer-causing free radicals.

Salt-inducible kinases found to limit the production of inflammatory molecules in human immune systems.

Recent advances and updates in oncology and cancer drug development.

Investigational injectable treatment combined with oral direct-acting antiviral drugs shows results after 8 weeks.

Only half of locally advanced rectal cancer patients receive standard therapy, which is affected by demographic factors.

Study finds medication reconciliation reduces error incidence in cancer patients undergoing chemotherapy.

Anavex 2-73, which is already in clinical trials for Alzheimer’s disease, recently received Orphan Drug Designation from the FDA for a rare genetic neurodevelopmental disorder.

Modified common flu adenovirus helps treat drug resistant cancers.

Study may lead to the development of treatments for disorders with damaged myelin sheath.

Individualized treatment for lymphoma may lead to a new standard of care.

Top articles of the week on Specialty Pharmacy Times.

Top news of the day from across the healthcare landscape.

Researchers examine the relationship between sleep disorders and melanoma.

Numerous factors besides adherence influence effective medication management.

Various approaches needed for immunotherapy efficacy to translate into significant real world outcomes.

Alecensa found superior to crizotinib in advanced or recurrent, ALK-positive non-small cell lung cancer.

Increased gut bacteria linked to inflammation among children with multiple sclerosis.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses initiatives to optimize medication adherence.

Mutations that affect protein levels impact tumor growth.

Top news of the day from across the healthcare landscape.

Endocrinologists seek to create an observational registry so researchers can study thyroid incidentalomas systematically.

Knowing the details about new HIV diagnoses can help pharmacists better understand the infection.

Atezolizumab (Tecentriq) approved for locally advanced or metastatic urothelial carcinoma.

Pharmacists can have a positive influence on medication adherence and several other factors in type 2 diabetes.

Drug-drug and drug-food interactions are evaluated in 58 oral chemotherapeutics.

Uneven distribution of the signaling protein c-Myc could aid the development of cancer vaccines.